Cargando…
Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
AIMS: Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used...
Autores principales: | Schueler, Stephan, Silvestry, Scott C., Cotts, William G., Slaughter, Mark S., Levy, Wayne C., Cheng, Richard K., Beckman, Jennifer A., Villinger, Jonas, Ismyrloglou, Eleni, Tsintzos, Stelios I., Mahr, Claudius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318455/ https://www.ncbi.nlm.nih.gov/pubmed/34047072 http://dx.doi.org/10.1002/ehf2.13401 |
Ejemplares similares
-
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device
por: Silvestry, Scott C., et al.
Publicado: (2020) -
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device
por: Mahr, Claudius, et al.
Publicado: (2020) -
Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices
por: Dimarakis, Ioannis, et al.
Publicado: (2022) -
Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
por: Faldu, Priyansh, et al.
Publicado: (2022) -
Ethical challenges with the left ventricular assist device as a destination therapy
por: Rizzieri, Aaron G, et al.
Publicado: (2008)